Beyond PARP-POLθ as an anticancer target

被引：64
作者：
Higgins, Geoff S. [1 ]
Boulton, Simon J. [2 ,3 ]
机构：
[1] Univ Oxford, Inst Radiat Oncol, Canc Res UK Med Res Council Oxford, Old Rd,Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England
[2] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England
[3] Artios Pharma Ltd, Babraham Res Campus, Cambridge CB22 3AT, England
来源：
SCIENCE | 2018年 / 359卷 / 6381期
关键词：
POLYMERASE-THETA; REPAIR; RECOMBINATION; CANCER; OLAPARIB; THERAPY; TUMORS; TRIAL; CELLS; NHEJ;
D O I：
10.1126/science.aar5149
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1217 / +
页数：2
相关论文
共 14 条
[1]   Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial [J].
Bang, Yung-Jue ;
Xu, Rui-Hua ;
Chin, Keisho ;
Lee, Keun-Wook ;
Park, Se Hoon ;
Rha, Sun Young ;
Shen, Lin ;
Qin, Shukui ;
Xu, Nong ;
Im, Seock-Ah ;
Locker, Gershon ;
Rowe, Phil ;
Shi, Xiaojin ;
Hodgson, Darren ;
Liu, Yu-Zhen ;
Boku, Narikazu .
LANCET ONCOLOGY, 2017, 18 (12) :1637-1651
[2]   Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [J].
Bryant, HE ;
Schultz, N ;
Thomas, HD ;
Parker, KM ;
Flower, D ;
Lopez, E ;
Kyle, S ;
Meuth, M ;
Curtin, NJ ;
Helleday, T .
NATURE, 2005, 434 (7035) :913-917
[3]   Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair [J].
Ceccaldi, Raphael ;
Liu, Jessica C. ;
Amunugama, Ravindra ;
Hajdu, Ildiko ;
Primack, Benjamin ;
Petalcorin, Mark I. R. ;
O'Connor, Kevin W. ;
Konstantinopoulos, Panagiotis A. ;
Elledge, Stephen J. ;
Boulton, Simon J. ;
Yusufzai, Timur ;
D'Andrea, Alan D. .
NATURE, 2015, 518 (7538) :258-U306
[4]   Excess Polθ functions in response to replicative stress in homologous recombination-proficient cancer cells [J].
de Rugy, T. Goullet ;
Bashkurov, M. ;
Datti, A. ;
Betous, R. ;
Guitton-Sert, L. ;
Cazaux, C. ;
Durocher, D. ;
Hoffmann, J. S. .
BIOLOGY OPEN, 2016, 5 (10) :1485-1492
[5]   Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [J].
Farmer, H ;
McCabe, N ;
Lord, CJ ;
Tutt, ANJ ;
Johnson, DA ;
Richardson, TB ;
Santarosa, M ;
Dillon, KJ ;
Hickson, I ;
Knights, C ;
Martin, NMB ;
Jackson, SP ;
Smith, GCM ;
Ashworth, A .
NATURE, 2005, 434 (7035) :917-921
[6]   A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown [J].
Higgins, Geoff S. ;
Prevo, Remko ;
Lee, Yin-Fai ;
Helleday, Thomas ;
Muschel, Ruth J. ;
Taylor, Steve ;
Yoshimura, Michio ;
Hickson, Ian D. ;
Bernhard, Eric J. ;
McKenna, W. Gillies .
CANCER RESEARCH, 2010, 70 (07) :2984-2993
[7]   When Genome Maintenance Goes Badly Awry [J].
Kass, Elizabeth M. ;
Moynahan, Mary Ellen ;
Jasin, Maria .
MOLECULAR CELL, 2016, 62 (05) :777-787
[8]   DNA polymerase θ is preferentially expressed in lymphoid tissues and upregulated in human cancers [J].
Kawamura, K ;
Bahar, R ;
Seimiya, M ;
Chiyo, M ;
Wada, A ;
Okada, S ;
Hatano, M ;
Tokuhisa, T ;
Kimura, H ;
Watanabe, S ;
Honda, I ;
Sakiyama, S ;
Tagawa, M ;
O-Wang, JY .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (01) :9-16
[9]   Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial [J].
Ledermann, Jonathan ;
Harter, Philipp ;
Gourley, Charlie ;
Friedlander, Michael ;
Vergote, Ignace ;
Rustin, Gordon ;
Scott, Clare L. ;
Meier, Werner ;
Shapira-Frommer, Ronnie ;
Safra, Tamar ;
Matei, Daniela ;
Fielding, Anitra ;
Spencer, Stuart ;
Dougherty, Brian ;
Orr, Maria ;
Hodgson, Darren ;
Barrett, J. Carl ;
Matulonis, Ursula .
LANCET ONCOLOGY, 2014, 15 (08) :852-861
[10]   PARP inhibitors: Synthetic lethality in the clinic [J].
Lord, Christopher J. ;
Ashworth, Alan .
SCIENCE, 2017, 355 (6330) :1152-1158
12